Prestige Consumer Healthcare Inc. Buyback
OLI recorded this information on 3/2/2020
Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that the Company's Board of Directors authorized the repurchase of up to $25.0 million of the Company's issued and outstanding common stock. Separately, the Company plans to present at the Raymond James Institutional Investors Conference at 8:40 a.m. ET today, March 2nd.
Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. develops, manufactures, markets, sells and distributes over-the-counter (OTC) healthcare products to mass merchandisers and drug, food, dollar, convenience, club and e-commerce stores in North America and in Australia and certain other international markets. Co.'s portfolio of OTC Healthcare products includes, among others, Clear Eyes eye and ear care products, Compound W wart removal, Chloraseptic sore throat liquids and lozenges, DenTek oral care products, Luden's cough drops, Monistat women's health products, Nix lice and parasite treatment products and Fess Nasal Saline Sprays and Washes.
PBH SEC Filing Email Alerts Service
Open the PBH Page at The Online Investor »
Free PBH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.50 out of 4)